Breaking News Instant updates and real-time market news.

ALNA

Allena Pharmaceuticals

$1.75

0.09 (5.42%)

11:25
11/19/19
11/19
11:25
11/19/19
11:25

Wedbush emerging pharma analyst to hold an analyst/industry conference call

Emerging Pharmaceuticals Analyst Moussatos, along with Dr. David Goldfarb, Clinical Chief of Nephrology at NYU School of Medicine, discuss the clinical relevance of URIROX-1 on an Analyst/Industry conference call to be held on November 19 at 12 pm.

  • 19

    Nov

ALNA Allena Pharmaceuticals
$1.75

0.09 (5.42%)

09/06/19
FBCO
09/06/19
NO CHANGE
Target $7
FBCO
Outperform
Allena Pharmaceuticals price target lowered to $7 from $26 at Credit Suisse
Credit Suisse analyst Martin Auster lowered his price target for Allena Pharmaceuticals and maintained an Outperform rating after taking a fresh look at reloxaliase ahead of uriROX-1 Phase 3 results expected in Q4. While Auster thinks this trial has a solid likelihood of being positive and views it as a meaningful catalyst for the name, he lowered his peak sales estimate for reloxaliase to $250M from $900M.
11/07/19
BARD
11/07/19
NO CHANGE
Target $20
BARD
Outperform
Allena Pharmaceuticals selloff today a buying opportunity, says Baird
Baird analyst Madhu Kumar views the selloff today in shares of Allena Pharmaceuticals as a buying opportunity. With reloxaliase meeting the primary endpoint of urinary oxalate reductions versus placebo with an absolute 22.6% urinary oxalate decline from baseline, the analyst believes the URIROX-1 trial reads positively to the second Phase 3 trial, URIROX-2. He reiterates an Outperform rating on Allena with a $20 price target. The analyst believes the market's reaction is wrong with the stock down 47% to $3.08.
11/07/19
ROTH
11/07/19
NO CHANGE
Target $31
ROTH
Buy
Allena's high placebo result in URIROX-1 a 'red herring,' says Roth Capital
Roth Capital analyst Yasmeen Rahimi tells investors in a research note that she thinks Allena Pharmaceuticals is getting "unnecessarily punished" on Thursday following positive URIROX-1 topline data on the basis of higher placebo response, smaller treatment effect and next steps for securing regulatory approval, saying she thinks URIROX-1 data tees up with URIROX-2 for success. In her view, the higher than expected placebo result is a "complete red herring," and keeps a Buy rating and $31 price target on the shares.
11/08/19
RILY
11/08/19
NO CHANGE
Target $11
RILY
Buy
Allena Pharmaceuticals selloff yesterday overdone, says B. Riley FBR
B. Riley FBR analyst Mayank Mamtani lowered his price target for Allena Pharmaceuticals to $11 from $20 saying clinical meaningfulness of reloxaliase's effect remains to be answered in the second Phase III URIROX-2 study. This increases skepticism around its market opportunity, says Mamtani, who cut his penetration assumption by half, driving his peak sales estimate to $183M from $367M. The analyst, whoever, views yesterday's selloff as overdone and keeps a Buy rating on Allena Pharmaceuticals.

TODAY'S FREE FLY STORIES

RMED

Ra Medical Systems

$1.22

-0.08 (-6.15%)

16:13
12/06/19
12/06
16:13
12/06/19
16:13
Hot Stocks
Ra Medical Systems receives noncompliance notice from NYSE »

Ra Medical Systems…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

LHX

L3Harris Technologies

$192.49

-0.98 (-0.51%)

16:12
12/06/19
12/06
16:12
12/06/19
16:12
Hot Stocks
L3Harris receives $50M follow-on order for HF radios from USMC »

L3Harris Technologies has…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

MRVL

Marvell

$24.16

0.715 (3.05%)

, NXPI

NXP Semiconductors

$118.43

1.28 (1.09%)

16:08
12/06/19
12/06
16:08
12/06/19
16:08
Earnings
Marvell cuts Q4 revenue view to $710M +/- 3% from $750M +/- 3% »

Q4 consensus $732.94M.…

MRVL

Marvell

$24.16

0.715 (3.05%)

NXPI

NXP Semiconductors

$118.43

1.28 (1.09%)

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 12

    Dec

  • 06

    Jan

DHR

Danaher

$148.23

1.16 (0.79%)

16:06
12/06/19
12/06
16:06
12/06/19
16:06
Options
Danaher rev/con volume near 100K is highest to date »

Danaher rev/con volume…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 06

    Dec

CLDX

Celldex

$2.55

(0.00%)

16:05
12/06/19
12/06
16:05
12/06/19
16:05
Syndicate
Breaking Syndicate news story on Celldex »

Celldex files $150M mixed…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

CNS

Cohen & Steers

$67.14

-0.17 (-0.25%)

, INB

Integrated BioPharma

$9.10

(0.00%)

16:03
12/06/19
12/06
16:03
12/06/19
16:03
Hot Stocks
Cohen & Steers announces approval of Global Income Builder reorganization »

Cohen & Steers Global…

CNS

Cohen & Steers

$67.14

-0.17 (-0.25%)

INB

Integrated BioPharma

$9.10

(0.00%)

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 26

    Feb

ENSV

Enservco

$0.21

0.005 (2.40%)

16:03
12/06/19
12/06
16:03
12/06/19
16:03
Hot Stocks
Enservco discloses NYSE non-compliance letter »

Enservco announced it has…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

NEM

Newmont Goldcorp

$39.84

-0.18 (-0.45%)

, ABX

Symbol changed to GOLD

$0.00

(0.00%)

15:45
12/06/19
12/06
15:45
12/06/19
15:45
Conference/Events
Odeon Capital metals/mining analyst to hold an analyst/industry conference call »

Analysts, along with Tony…

NEM

Newmont Goldcorp

$39.84

-0.18 (-0.45%)

ABX

Symbol changed to GOLD

$0.00

(0.00%)

KL

Kirkland Lake Gold

$40.53

-0.52 (-1.27%)

EVN

Eaton Vance Municipal Income Trust

$12.96

0.06 (0.47%)

NST

Nstar

$0.00

(0.00%)

AUY

Yamana Gold

$3.58

-0.195 (-5.17%)

DGC

Direct General Corp.

$0.00

(0.00%)

SAR

Saratoga Investment

$25.32

0.18 (0.72%)

EDV

Envision Development Corp.

$135.32

-1.28 (-0.94%)

CEY

Certegy

$22.88

(0.00%)

RSG

Republic Services

$88.92

0.675 (0.76%)

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

15:45
12/06/19
12/06
15:45
12/06/19
15:45
General news
Treasury Market Summary »

Treasury Market Summary:…

XOM

Exxon Mobil

$69.57

1.16 (1.70%)

15:30
12/06/19
12/06
15:30
12/06/19
15:30
Hot Stocks
Exxon Mobil Treasurer sells 8K shares of common stock »

In a regulatory filing,…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

S

Sprint

$5.46

0.055 (1.02%)

, TMUS

T-Mobile

$77.55

0.57 (0.74%)

15:26
12/06/19
12/06
15:26
12/06/19
15:26
Periodicals
Sprint, T-Mobile discussing last-minute settlement with AGs, FBN says »

Fox Business…

S

Sprint

$5.46

0.055 (1.02%)

TMUS

T-Mobile

$77.55

0.57 (0.74%)

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 06

    Dec

  • 09

    Dec

  • 16

    Dec

XOM

Exxon Mobil

$69.56

1.15 (1.68%)

15:24
12/06/19
12/06
15:24
12/06/19
15:24
Hot Stocks
Exxon Mobil Controller sells 9.6K shares of common stock »

In a regulatory filing,…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

DB

Deutsche Bank

$7.22

0.035 (0.49%)

, COF

Capital One

$101.65

2.06 (2.07%)

15:22
12/06/19
12/06
15:22
12/06/19
15:22
Periodicals
Trump asks Supreme Court to block subpoenas for bank records, Politico says »

Politico's Andrew…

DB

Deutsche Bank

$7.22

0.035 (0.49%)

COF

Capital One

$101.65

2.06 (2.07%)

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 26

    Feb

HSBC

HSBC

$36.87

0.505 (1.39%)

15:17
12/06/19
12/06
15:17
12/06/19
15:17
Periodicals
HSBC exec Moses to announce departure next week, Bloomberg says »

HSBC chief risk officer…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

$NSD

NASDAQ Market Internals

$0.00

(0.00%)

15:17
12/06/19
12/06
15:17
12/06/19
15:17
Technical Analysis
NASDAQ market internals summary »

Volume is average for…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

$NYE

NYSE Market Internals

$0.00

(0.00%)

15:16
12/06/19
12/06
15:16
12/06/19
15:16
Technical Analysis
NYSE market internals summary »

Volume is average for…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

15:15
12/06/19
12/06
15:15
12/06/19
15:15
General news
U.S. consumer credit surged a solid $18.9 B in October »

U.S. consumer credit…

JBSAY

JBS S.A.

$0.00

(0.00%)

15:09
12/06/19
12/06
15:09
12/06/19
15:09
Periodicals
JBS to redomicile headquarters as part of U.S. IPO, Reuters reports »

JBS S.A. plans on…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

IWM

iShares Trust Russell 2000 Index Fund

$162.91

1.96 (1.22%)

, RUT

Russell 2000 Index

$0.00

(0.00%)

15:08
12/06/19
12/06
15:08
12/06/19
15:08
Technical Analysis
On The Fly: Weekly technical notes for Russell 2000 »

The Russell 2000 (RUT)…

IWM

iShares Trust Russell 2000 Index Fund

$162.91

1.96 (1.22%)

RUT

Russell 2000 Index

$0.00

(0.00%)

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

XLY

Consumer Discretionary Sector SPDR

$121.77

0.99 (0.82%)

, XLI

Industrial Select Sector SPDR

$81.11

0.975 (1.22%)

15:07
12/06/19
12/06
15:07
12/06/19
15:07
Technical Analysis
On The Fly: Weekly technical notes for S&P 500 »

For the week the S&P…

XLY

Consumer Discretionary Sector SPDR

$121.77

0.99 (0.82%)

XLI

Industrial Select Sector SPDR

$81.11

0.975 (1.22%)

SPY

SPDR S&P 500 ETF Trust

$314.95

2.91 (0.93%)

SPX

S&P 500

$0.00

(0.00%)

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

15:03
12/06/19
12/06
15:03
12/06/19
15:03
General news
Consumer Credit data reported »

October Consumer Credit…

DIS

Disney

$147.99

0.52 (0.35%)

15:01
12/06/19
12/06
15:01
12/06/19
15:01
Periodicals
Disney Japan apologizes for stealthy 'Frozen II' advertisements, NAR says »

Disney has apologized for…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

ICE

IntercontinentalExchange

$94.20

0.56 (0.60%)

14:56
12/06/19
12/06
14:56
12/06/19
14:56
Periodicals
Regulators reject NYSE direct listing plan, Axios reports »

The Securities and…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

CCS

Century Communities

$28.32

0.03 (0.11%)

14:46
12/06/19
12/06
14:46
12/06/19
14:46
Conference/Events
Century Communities management to meet with Wedbush »

Meeting to be held in…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 11

    Dec

14:45
12/06/19
12/06
14:45
12/06/19
14:45
General news
Treasury Action: supply heats up with $78 B in coupons, »

Treasury Action: supply…

Get Full Fly Access

Breaking market intelligence sent straight to you
Our team of experts analyze every news story and filter out the noise to deliver real-time market moving news.
Up-to-date information on important industry events
Get real-time updates on events that are moving the market—from conferences and calls to syndicate announcements.
News focused on the companies in your portfolio
Create up to 12 portfolios with 150 stocks each, and see how active they are in market news.